Eli Lilly to invest $5B on Virginia plant amid Trump's pharma tariff threats
Pharmaceutical giant Eli Lilly expanded its Virginia facility investment plans to $5 billion from original $2.1 billion amid the Trump administration tariff threats on drug imports.
